Synthesis and Characterization of Chitosan-Based Nanodelivery Systems to Enhance the Anticancer Effect of Sorafenib Drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma Cells

Synthesis and characterization of folic acid-chitosan nanoparticles loaded with thymoquinone to target ovarian cancer cells

(2020) İskender İnce et al.   JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY

Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles

(2020) Ningxi Li et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer

(2019) Dnyaneshwar Kalyane et al.   Materials Science & Engineering C-Materials for Biological Applications

Evaluation of the Release Kinetics of a Pharmacologically Active Substance from Model Intra-Articular Implants Replacing the Cruciate Ligaments of the Knee

(2019) Dorota Wojcik-Pastuszka et al.   Materials

Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma

(2019) Mahmoud M.A. Elsayed et al.   International Journal of Nanomedicine

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis

(2017) Daniela Sia et al.   GASTROENTEROLOGY

Hepatobiliary Cancers

(2017) Al B. Benson et al.   Journal of the National Comprehensive Cancer Network

Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment

(2016) Yanan Xiao et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications

(2016) Loïc Bugnicourt et al.   PROGRESS IN POLYMER SCIENCE

Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

(2016) Masatoshi Kudo et al.   Liver Cancer

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics

(2015) Yu-Ji Li et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nanostructural Systems Developed with Positive Charge Generation to Drug Delivery

(2014) Fei-Fei An et al.   Advanced Healthcare Materials

Facing the Truth about Nanotechnology in Drug Delivery

(2013) Kinam Park   ACS Nano

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

(2013) Nicolas Bertrand et al.   ADVANCED DRUG DELIVERY REVIEWS

Update on current and potential nanoparticle cancer therapies

(2013) Jonathan S. Rink et al.   CURRENT OPINION IN ONCOLOGY

Molecular mechanisms of sorafenib action in liver cancer cells

(2012) Melchiorre Cervello et al.   CELL CYCLE

Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo

(2012) R. Coriat et al.   MOLECULAR CANCER THERAPEUTICS

Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer

(2012) Do Kim et al.   Nanoscale Research Letters

Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

(2011) Timothy M. Pawlik et al.   JOURNAL OF CLINICAL ONCOLOGY

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

(2011) H. Cabral et al.   Nature Nanotechnology

Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties andin vivobehavior

(2010) Chen Fang et al.   Nanomedicine

Risk of hand-foot skin reaction with sorafenib: A systematic review and meta-analysis

(2008) David Chu et al.   ACTA ONCOLOGICA